In Vitro Inhibitory Effect of Protopanaxadiol Ginsenosides on Tumor Necrosis Factor (TNF)-α Production and its Modulation by Known TNF-α Antagonists

Abstract

Ginsenosides are the major principles of Panax ginseng C. A. Meyer (Araliaceae) used as a mild oriental folk medicine. In this report, we have examined the inhibitory potency of protopanaxadiol ginsenosides (PPDGs) such as Rb₁, Rb₂ and Rc, and their co-treatment effect with known tumor necrosis factor (TNF)-α antagonists on TNF-α production in either murine (RAW264.7) or human (U937) macrophages stimulated with lipopolysaccharide (LPS). Rb₁, and Rb₂ strongly suppressed TNF-α production in RAW264.7 cells with an IC₅₀ of 56.5 and 27.5 μM, respectively, and in differentiated U937 cells with an IC₅₀ of 51.3, and 26.8 μM, respectively. The inhibitory activity of Rb₁ and Rb₂ was significantly increased by pharmacological agents against protein kinase C, protein tyrosine kinase, and protein kinase A, and anti-rheumatoid arthritis drugs, such as chloroquine and steroid drugs. In contrast, only cyclic AMP phosphodiesterase (cAMP PDE) inhibitors among cAMP-elevating agents did not change the inhibitory potency of PPDGs. These data suggest that PPDGs may possess potential therapeutic efficacy against TNF-α mediated disease and the therapeutic potency of PPDGs may be enhanced when co-treated with various kinds of known TNF-α antagonists but not with cAMP PDE inhibitors.

Key words

Panax ginseng - Araliaceae - protopanaxadiol ginsenosides - tumor necrosis factor-α production, drug interaction

References

• 1 Matsuda H, Samukawa K, Kubo M. Studies of Panax japonicus fibrinolysis.  Planta Medica. 1989;  56 19-23
• 2 Mochizuki M, Yoo Y C, Matsuzawa K, Sato K, Saiki I, Tono-oka S, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, on red ginseng.  Biological and Pharmaceutical Bullutin. 1995;  18 1197-202
• 3 Shinkai K, Akedo H, Mukai M, Imamura F, Isoai A, Kobayashi M, et al. Inhibition of in vitro tumor cell invasion by ginsenoside Rg3.  Japanese Journal of Cancer Research. 1996;  87 357-62
• 4 Vilcek J, Lee T H. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions.  Journal of Biological Chemistry. 1991;  266 7313-6
• 5 Sekut L, Connolly K M. Pathophysiology and regulation of TNF-α in inflammation.  Drug News Perspective. 1996;  9 261-9
• 6 Fye K H. New treatments for rheumatoid arthritis. Available and upcoming slow-acting antirheumatic drugs.  Postgraduate Medicine. 1999;  106 82-92
• 7 Cho J Y, Park J, Yoo E S, Baik K U, Park M H. Effect of ginseng saponin on tumor necrosis factor-α production and T cell proliferation.  Yakhak Hoeji. 1998;  43 296-301
• 8 Cho J Y, Park J, Yoo E S, Baik K U, Jung J H, Lee J, et al.. Inhibitory effect of sesquiterpene lactones from Saussurea lappa on tumor necrosis factor-α production in murine macrophage-like cells.  Planta Medica. 1998;  64 594-7
• 9 Cho J Y, Kim P S, Park J, Chae S H, Yoo E S, Baik K U, Park M H. Immunomodulatory effect of arctigenin, a lignan compound, on tumour necrosis factor-α and nitric oxide production, and lymphocyte proliferation.  Journal of Pharmaceutical Pharmacology. 1999;  51 1267-73
• 10 Cho J Y, Park J, Kim P S, Chae S H, Yoo E S, Baik K U, et al. Inhibitory effect of medicinal plants on TNF-α production from LPS-stimulated RAW264.7 cells.  Natural Product Sciences. 1999;  5 12-9
• 11 Cho J Y, Park J, Yoo E S, Baik K U, Park M H. Eudesmin inhibits tumor necrosis factor-α production and T cell proliferation.  Archives of Pharmaceutical Research. 1999;  22 348-53
• 12 Cho J Y, Lee J, Park J, Park M H. Isolation of inhibitory components on TNF-α production from Angelica koreana .  Yakhak Hoeji. 1998;  43 125-31
• 13 Cho J Y, Kim P S, Park J, Chae S H, Yoo E S, Baik K U, et al. Inhibitor of tumor necrosis factor-α production in lipopolysaccharide-stimulated RAW264.7 cells from Amorpha fruticosa .  Journal of Ethnopharmacology. 2000;  70 127-33
• 14 Kikuchi Y, Sasa H, Kita T, Hirata J, Tode T, Nagata I. Inhibition of human ovarian cancer cell proliferation. In vitro by ginsenoside Rh2 and adjuvant effects to cisplatin in vivo .  Anticancer Drugs. 1991;  2 63-7
• 15 Lang F, Robert J M, Boucrot P, Welin L, Petit J Y. New anti-inflammatory compounds that inhibit tumor necrosis factor production: Probable interaction with protein kinase C activation.  Journal of Pharmacology and Experimental Therapy. 1995;  275 171-6
• 16 Jeong J Y, Ju D M. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages.  Journal of Immunology. 1997;  158 4901-7
• 17 Ollivier V, Parry G CN, Cobb R R, de Prost D, Mackman N. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells.  Journal of Biological Chemistry. 1996;  271 20828-35
• 18 Nikaido T, Ohmoto T, Sankawa U, Tanaka O, Kasai R, Shoji J, et al. Inhibitors of cyclic AMP phosphodiesterase in Panax ginseng C. A. Meyer and Panax japonicus C. A. Meyer.  Chemical and Pharmaceutical Bull.. 1984;  32 1477-83
• 19 Sinha B, Semmler J, Eisenhut T, Eigler A, Endres S. Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids.  European Journal of Immunology. 1996;  25 147-53
• 20 Bertini R, Garattini S, Delgado R, Ghezzi P. Pharmacological activities of chlorpromazine involved in the inhibition of tumor necrosis factor production in vivo in mice.  Immunology. 1993;  79 217-9